BioMarin Pharmaceutical Inc. buy StockNews.com
Start price
29.04.23
/
50%
€88.08
Target price
29.04.24
-
Performance (%)
-13.03%
End price
30.04.24
€76.60
Summary
This prediction ended on 30.04.24 with a price of €76.60. The prediction for BioMarin Pharmaceutical Inc. disappointed with a performance of -13.03%. StockNews_com has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -1.003% | -1.003% | -28.278% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by StockNews_com for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€65.26
22.02.25
22.02.25
-
22.02.26
22.02.26
-30.43%
12.12.25
12.12.25
Stopped prediction by StockNews_com for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€66.60
10.03.25
10.03.25
-
10.03.26
10.03.26
-31.83%
12.12.25
12.12.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€67.70
02.03.25
02.03.25
-
02.03.26
02.03.26
-32.94%
12.12.25
12.12.25